The Role of Adrenal Metastasectomy in the New Era of Immune Checkpoint Blockade and/or Targeted Therapy

Moderator(s)

• 

  Patricia Cronin, MD, FRCS

  Assistant Professor of Surgery
  Mayo Clinic
  Pheonix, AZ, United States

  Disclosure(s): No financial relationships to disclose
• 

  Carmen Solórzano, MD (she/her/hers)

  Professor and Chair, Department of Surgery
  Vanderbilt University
  Nashville, Tennessee, United States

  Disclosure(s): No financial relationships to disclose

Presentations:

• 12:16 PM – 12:26 PM

  Evaluation of Adrenal Masses in Patients with Secondary Malignancy
  

  Presenter: Linwah Yip, MD – University of Pittsburgh Medical Center
• 12:27 PM – 12:37 PM

  Adrenal Metastases in the Era of Targeted/Immunotherapy from an Oncologist's Perspective
  

  Presenter: Philip J. Saylor, MD (he/him/his) – Massachusetts General Hospital / Harvard Medical School
• 12:38 PM – 12:48 PM

  Why and When can Adrenal Metastasectomy be Appropriate from a Surgeon Perspective?
  

  Presenter: Paul H. Graham, MD – UT MD Anderson Cancer Center
• 12:49 PM – 12:59 PM

  Surgical Considerations for Adrenal Metastasectomy
  

  Presenter: Heather Wachtel, MD (she/her/hers) – University of Pennsylvania
• 1:00 PM – 1:15 PM

  Questions and Discussion
  

  Panelist: Linwah Yip, MD – University of Pittsburgh Medical Center

  Panelist: Heather Wachtel, MD (she/her/hers) – University of Pennsylvania

  Panelist: Philip J. Saylor, MD (he/him/his) – Massachusetts General Hospital / Harvard Medical School

  Panelist: Paul H. Graham, MD – UT MD Anderson Cancer Center